Structures of insect Imp-L2 suggest an alternative strategy for regulating the bioavailability of insulin-like hormones.

Roed NK, Viola CM, Kristensen O, Schluckebier G, Norrman M, Sajid W, Wade JD, Andersen AS, Kristensen C, Ganderton TR, Turkenburg JP, De Meyts P, Brzozowski AM
Nat Commun 9(1):3860 (2018 Sep 21)
PMID: 30242155
doi: 10.1038/s41467-018-06192-3 		Submitted to SASBDB: 2018 Jun 21
Published in SASBDB:

SASDDS8 – Neural/ectodermal development factor IMP-L2

Neural/ectodermal development factor IMP-L2 experimental SAS data
Neural/ectodermal development factor IMP-L2 Kratky plot
Sample: Neural/ectodermal development factor IMP-L2 dimer, 60 kDa Drosophila melanogaster protein
Buffer: phosphate buffered saline, pH: 7.4
Experiment: SAXS data collected at ID14-3, ESRF on 2011 Nov 20
RgGuinier 3.1 nm
Dmax 12.0 nm
VolumePorod 93 nm3

SASDDT8 – Neural/ectodermal development factor IMP-L2 in complex with insulin-like peptide 5 (DILP5)

Insulin-like peptide 5Neural/ectodermal development factor IMP-L2 experimental SAS data
Insulin-like peptide 5 Neural/ectodermal development factor IMP-L2 Kratky plot
Sample: Insulin-like peptide 5 monomer, 5 kDa Drosophila melanogaster protein
Neural/ectodermal development factor IMP-L2 monomer, 30 kDa Drosophila melanogaster protein
Buffer: phosphate buffered saline, pH: 7.4
Experiment: SAXS data collected at ID14-3, ESRF on 2011 Nov 20
RgGuinier 2.6 nm
Dmax 9.0 nm
VolumePorod 55 nm3